$GTHX G1 Therapeutics, Inc. Insider Trading Week 19/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. in week 19/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 307,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 307,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 317,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 317,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 327,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Option Exercise | M | 0.39 | 10,000 | 3,900 | 327,286 | ||
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.54 | 10,000 | 205,413 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.54 | 10,000 | 205,413 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.07 | 10,000 | 200,691 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 20.07 | 10,000 | 200,691 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 19.10 | 10,000 | 190,997 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Sell | S | 19.10 | 10,000 | 190,997 | 41,000 | 51 K to 41 K (-19.61 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 13 2021 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | Buy | M | 0.39 | 10,000 | 3,900 | 51,000 | 41 K to 51 K (+24.39 %) | |
| May 11 2021 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Chief Medical Offic ... | Option Exercise | M | 0.30 | 10,000 | 3,000 | 65,000 | |
| May 11 2021 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Chief Medical Offic ... | Buy | M | 0.30 | 10,000 | 3,000 | 53,300 | 43.3 K to 53.3 K (+23.09 %) |